naltrexone and Adenocarcinoma

naltrexone has been researched along with Adenocarcinoma in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19901 (12.50)18.7374
1990's1 (12.50)18.2507
2000's5 (62.50)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
King, T; Navratilova, E; Okun, A; Porreca, F; Remeniuk, B; Sukhtankar, D; Xie, JY1
Berkson, AJ; Berkson, BM; Rubin, DM2
McLaughlin, PJ; Zagon, IS1
Levin, RJ; McLaughlin, PJ; Ohlsson-Wilhelm, BM; Roesener, CD; Verderame, MF; Zagon, IS1
Hodgson, DM; Taylor, AN; Yirmiya, R1
Aylsworth, CF; Hodson, CA; Meites, J1
Abou-Issa, H; Tejwani, GA1

Other Studies

8 other study(ies) available for naltrexone and Adenocarcinoma

ArticleYear
Behavioral and neurochemical analysis of ongoing bone cancer pain in rats.
    Pain, 2015, Volume: 156, Issue:10

    Topics: Adenocarcinoma; Analgesics, Opioid; Anesthetics, Local; Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Bone Neoplasms; Cell Line, Tumor; Diclofenac; Disease Models, Animal; Female; Gyrus Cinguli; Lidocaine; Morphine; Naltrexone; Narcotic Antagonists; Nucleus Accumbens; Pain; Rats; Rats, Inbred F344

2015
Revisiting the ALA/N (alpha-lipoic acid/low-dose naltrexone) protocol for people with metastatic and nonmetastatic pancreatic cancer: a report of 3 new cases.
    Integrative cancer therapies, 2009, Volume: 8, Issue:4

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Fatal Outcome; Female; Humans; Infusions, Intravenous; Liver Neoplasms; Male; Naltrexone; Pancreatic Neoplasms; Thioctic Acid

2009
Opioid growth factor (OGF) inhibits anchorage-independent growth in human cancer cells.
    International journal of oncology, 2004, Volume: 24, Issue:6

    Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Cell Adhesion; Cell Division; Colonic Neoplasms; Colony-Forming Units Assay; Enkephalin, Methionine; Head and Neck Neoplasms; Humans; Naloxone; Naltrexone; Narcotic Antagonists; Pancreatic Neoplasms; Receptors, Opioid; Transplantation, Heterologous; Tumor Cells, Cultured

2004
The long-term survival of a patient with pancreatic cancer with metastases to the liver after treatment with the intravenous alpha-lipoic acid/low-dose naltrexone protocol.
    Integrative cancer therapies, 2006, Volume: 5, Issue:1

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Humans; Immunohistochemistry; Infusions, Intravenous; Liver Neoplasms; Male; Middle Aged; Naltrexone; Neoplasm Staging; Palliative Care; Pancreatic Neoplasms; Thioctic Acid; Time Factors; Treatment Outcome

2006
Opioid growth factor regulates the cell cycle of human neoplasias.
    International journal of oncology, 2000, Volume: 17, Issue:5

    Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Cell Cycle; Cell Division; Colonic Neoplasms; DNA Replication; Enkephalin, Methionine; Head and Neck Neoplasms; Humans; Naltrexone; Narcotic Antagonists; Neoplasm Proteins; Neoplasms; Pancreatic Neoplasms; Receptors, Opioid; Resting Phase, Cell Cycle; Tumor Cells, Cultured; Tumor Stem Cell Assay

2000
Intracerebroventricular interleukin-1beta impairs clearance of tumor cells from the lungs: role of brain prostaglandins.
    Journal of neuroimmunology, 2001, Sep-03, Volume: 119, Issue:1

    Topics: Adenocarcinoma; Animals; Brain; Cyclooxygenase Inhibitors; Diclofenac; Ibuprofen; Injections, Intraventricular; Interleukin-1; Lung Neoplasms; Male; Naltrexone; Narcotic Antagonists; Neoplasm Invasiveness; Neural Pathways; Norepinephrine; Prostaglandins; Rats; Rats, Inbred F344

2001
Opiate antagonists can inhibit mammary tumor growth in rats.
    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1979, Volume: 161, Issue:1

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Adenocarcinoma; Animals; Endorphins; Female; Mammary Neoplasms, Experimental; Naloxone; Naltrexone; Rats

1979
Antitumor activity of naltrexone and correlation with steroid hormone receptors.
    Biochemical and biophysical research communications, 1991, Mar-15, Volume: 175, Issue:2

    Topics: Adenocarcinoma; Animals; Body Weight; Endorphins; Female; Mammary Neoplasms, Experimental; Naltrexone; Rats; Receptors, Estrogen; Receptors, Opioid; Receptors, Progesterone

1991